Literature DB >> 16046031

Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia.

Edmund C Jenkins1, Milen T Velinov, Lingling Ye, Hong Gu, Shuyun Li, Edmund C Jenkins1, Susan Sklower Brooks, Deborah Pang, Darlynne A Devenny, Warren B Zigman, Nicole Schupf, Wayne P Silverman.   

Abstract

Telomere shortening has been recently correlated with Alzheimer's disease status. Therefore, we hypothesized that a possible association might exist for adults with Down syndrome (DS). Using blind, quantitative telomere protein nucleic acid FISH analyses of metaphase and interphase preparations from 18 age-matched trisomy 21 female study participants with and without dementia, we have observed increased telomere shortening in adults with DS and dementia (p < .01). From this initial study, we conclude that telomere shortening is associated with dementia in this high-risk population and suggest that additional research may show that telomere shortening may be a biological marker of dementia status.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046031     DOI: 10.1016/j.neurobiolaging.2005.05.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns.

Authors:  Edmund C Jenkins; Lingling Ye; Milen Velinov; Sharon J Krinsky-McHale; Warren B Zigman; Nicole Schupf; Wayne P Silverman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-16       Impact factor: 3.568

3.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

Review 4.  Cognitive impairment, genomic instability and trace elements.

Authors:  A Meramat; N F Rajab; S Shahar; R Sharif
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

Review 5.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

6.  Plasma Amyloid Beta 1-42 and DNA Methylation Pattern Predict Accelerated Aging in Young Subjects with Down Syndrome.

Authors:  Rima Obeid; Ulrich Hübner; Marion Bodis; Juergen Geisel
Journal:  Neuromolecular Med       Date:  2016-05-27       Impact factor: 3.843

7.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

8.  Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome.

Authors:  Edmund C Jenkins; Lingling Ye; Hong Gu; Samantha A Ni; Charlotte J Duncan; Milen Velinov; Deborah Pang; Sharon J Krinsky-McHale; Warren B Zigman; Nicole Schupf; Wayne P Silverman
Journal:  Neurosci Lett       Date:  2008-06-18       Impact factor: 3.046

9.  Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene.

Authors:  Edmund C Jenkins; Flora Tassone; Lingling Ye; Hong Gu; Man Xi; Milen Velinov; W Ted Brown; Randi J Hagerman; Paul J Hagerman
Journal:  Am J Med Genet A       Date:  2008-06-15       Impact factor: 2.802

10.  Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease.

Authors:  J Nicholas Lukens; Vivianna Van Deerlin; Christopher M Clark; Sharon X Xie; F Brad Johnson
Journal:  Alzheimers Dement       Date:  2009-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.